Foventa Therapeutics Appoints Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer
Position
Chief Financial Officer
Company
Foventa Therapeutics
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Foventa Therapeutics has announced the appointment of Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer. They will work alongside the newly appointed CEO Olav Hellebø to advance FOV407 through its Phase IIb trial and secure funding.
Quick answer
Foventa Therapeutics Appoints Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer (September 2, 2026). Foventa Therapeutics is based in Cambridge, England, United Kingdom.
- Who is the new Chief Financial Officer at Foventa Therapeutics?
- Foventa Therapeutics named Julia Jones Chief Financial Officer, announced September 2, 2026.
- What did Foventa Therapeutics announce on September 2, 2026?
- Foventa Therapeutics has announced the appointment of Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer. They will work alongside the newly appointed CEO Olav Hellebø to advance FOV407 through its Phase IIb trial and secure funding.
- What does Foventa Therapeutics do?
- Foventa Therapeutics is a clinical-stage biotechnology company dedicated to preserving sight through the development of innovative ophthalmic medicines.
- Where is Foventa Therapeutics based?
- Foventa Therapeutics is based in Cambridge, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Allogene Therapeutics, Inc. (September 2, 2026), Eikon Therapeutics (September 3, 2026), Vertex Pharmaceuticals (September 2, 2026) and Priothera (September 3, 2026) also announced leadership changes within 45 days of Foventa Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Allogene Therapeutics Announces Retirement of CFO Geoffrey Parker (September 2, 2026)
- Eikon Therapeutics Appoints Ching-Pin Chang as Chief Scientific Officer (September 3, 2026)
- Vertex Pharmaceuticals Appoints Jonathan Poole as Chief Financial Officer (September 2, 2026)
- Priothera Appoints Nigel Clark as Chief Business Officer (September 3, 2026)
- Vaxcyte Appoints Luis Jodar as Chief Medical Officer and David McAvoy as Chief Legal Officer (September 3, 2026)
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer (September 1, 2026)
Who to call at Foventa Therapeutics, and when
A new leader at Foventa Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Foventa Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Foventa Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Foventa Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Foventa Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Foventa Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.